ABSTRACT
This chapter seeks to answer the question posed in the title and demonstrate that in brain natriuretic peptide (BNP), we do indeed have a biochemical marker which has emerged from the research arena to take its place in clinical practice as an aid to both the diagnosis of heart failure and as a potential way of monitoring its therapy.
